A randomized clinical trial finds crocin reduces macular thickness in mild-to-moderate diabetic retinopathy, suggesting potential therapeutic benefits.
Based on our findings, crocin was effective in reducing the thickness of the areas around the macula in mild-to-moderate DR. It is suggested that crocin can be considered an effective supplementary drug in preventing the progression and an adjuvant therapy for DR.
No takes yet. Share an insight, caveat, or question.
Sepahi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: